Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.
2.
FDA Approves CAR-T Product Use for Myeloma Early.
3.
The Truth About Apple AirPods
4.
Using AI, one can find cancer risk factors.
5.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
1.
From Birthmarks to Tumors: The Science Behind Infantile Hemangioma
2.
Modern Developments in Oncology for Specialists
3.
Exploring New Treatment Strategies for Mantle Cell Lymphoma
4.
CAR-T Therapy in Blood Cancers: Mechanisms, Efficacy, and Clinical Integration
5.
Innovative Advances in Oncology for Specialists
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
4.
Understanding the Role of Multidisciplinary Cancer Care
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation